Elevated PSA

Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. It is primarily found in semen where it functions to liquefy the semen to help fertilization. Small amounts of PSA circulate in the blood as a result of blood flowing through the prostate. The PSA does not have a function in the bloodstream. A high level is not harmful to you, it is simply an indication you may have prostate cancer.

Prostate cancer is the most commonly diagnosed non skin cancer in American men. It is estimated that around 300,000 patients will be diagnosed with prostate cancer this years and and 30-40,000 men will die of the disease.

Prostate cancer screening is an important health consideration for men, particularly as they age. The PSA is a blood test. The test measures the level of PSA concentration in the blood, Elevated PSA levels can indicate the presence of prostate cancer but they may also result from benign conditions such as prostatitis (infection or inflammation) or benign prostatic hyperplasia (BPH or enlarged prostate).

Recommendations for PSA Screening

The decision to undergo PSA screening should be based on individual factors, including age, family history of prostate cancer, and overall health. The general guidelines recommend:

  • Men aged 50 and older: Discuss the benefits and risks of PSA screening with a healthcare provider.
  • Men at higher risk (e.g., African American men or those with a family history of prostate cancer): Consider screening starting at age 45.
  • Men with a significantly higher risk: For those with multiple family members affected by prostate cancer, starting screening as early as age 40 may be advisable.

Interpreting PSA Test Results

A PSA below 1.5 ng/ml means a man’s risk of prostate cancer is very low. As the number rises above 1.5 the risk of having prostate cancer also increases. As men age the average PSA levels also increase because our prostates grow and tend to leak more PSA into the bloodstream. Historically a cutoff PSA level below 4.0 ng/mL was typically considered normal, but this threshold can vary based on age and other factors. We tend to use age-specific PSA criteria to help assess a man’s risk of prostate cancer.

Here are some of the generally accepted age-specific PSA thresholds:

  • Ages 40-49: A PSA level of 0 to 2.5 ng/mL is considered normal. Levels above 2.5 ng/mL may warrant further investigation, given the lower baseline levels in this age group.
  • Ages 50-59: Normal PSA levels are typically between 0 and 3.5 ng/mL. Levels above this range may indicate a higher risk of prostate pathology.
  • Ages 60-69: PSA levels should generally be between 0 and 4.5 ng/mL. Elevated levels require further evaluation due to an increased risk of prostate cancer.
  • Ages 70 and older: A normal PSA level may range from 0 to 6.5 ng/mL. Higher levels may suggest an increased probability of prostate issues, including cancer.

These criteria are not absolute; individual factors such as family history, race, and previous prostate conditions also play significant roles in the interpretation of PSA results.

Next Steps After an Elevated PSA

  • Repeat Testing: A repeat PSA test may be recommended to confirm that the elevation is consistent.
  • Digital Rectal Exam (DRE): A DRE can help assess the prostate's size, shape, and texture to identify any abnormalities.
  • Imaging Tests: Depending on the situation, ultrasound or MRI might be utilized to visualize the prostate and identify potential problems. A prostate MRI (Magnetic Resonance Imaging) is a non-invasive imaging technique used to obtain detailed images of the prostate gland and surrounding tissues. This procedure is particularly valuable for diagnosing prostate conditions, including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis.
  • Other Blood or Urine Tests: Other tests can help determine overall cancer risk. Tests such as an iso-PSA or 4K score can help determine if a prostate biopsy should be done.
  • Biopsy: If there is a sustained elevation or other concerning signs, a prostate biopsy may be necessary to determine the presence of cancer.

Prostate Biopsy

During a prostate biopsy, small tissue samples are taken from the prostate gland for laboratory analysis.

The procedure is typically performed in our outpatient clinic. There are several methods for conducting a prostate biopsy, the most common of which is transrectal ultrasound-guided biopsy. A small ultrasound probe is inserted into the rectum to allow the physician to visualize the prostate and guide a needle to collect samples from specific areas.

Other techniques include transperineal biopsy, where samples are taken through the skin between the scrotum and rectum, and saturation biopsy, which involves taking more samples than standard methods to ensure thorough examination.

Patients may experience some discomfort or minor pain during and after the procedure. Serious complications of infection and bleeding can occur after the procedure but are uncommon.

The biopsy results help determine whether cancer is present, the aggressiveness of the disease, and guide treatment decisions if necessary.

A prostate biopsy is used to diagnose prostate cancer after a high PSA, a lump or irregularity, or abnormal prostate imaging (like MRI).

A prostate biopsy is done with the patient on their side or in lithotomy. After local anesthesia using an ultrasound placed into the rectum the urologist will inject local anesthesia and then survey the prostate using the ultrasound. Thin-core samples are taken via a trans-rectal or trans-perineal needle—typically 10–12 cores, though the number varies. If a patient has an abnormal MRI then additional biopsies are taken to target the suspicious area seen on the MRI. The procedure lasts 10-15 minutes.

A prostate biopsy checks for prostate cancer. The tissue also shows how aggressive the cancer is (Gleason score or WHO Grade Group) and how much cancer is present by looking at how much cancer is in each sample and how many samples are positive.

Possible Risks Include:

  • Bleeding (urine, rectum, semen) is common and may last a couple of days. Serious bleeding is rare but does occur.

  • Infection (may need antibiotics or hospitalization)

  • Urinary Retention needing temporary catheterization

  • Expected Pain/manageable with local anesthesia and oral pain meds

  • Possible false‑negative/false‑positive results leading to delayed diagnosis or unnecessary treatment.

Men choosing not to do a prostate biopsy have some alternative to determine cancer risk but there are no other tests that can officially diagnose the cancer other than a tissue sample. Often men have already had an MRI. A negative MRI decreases the chance of finding cancer on a biopsy but can’t totally rule out cancer. Blood or urine tests exist (4K score, iso-PSA, PHI, urine testing can help men classify their risk further prior to a biopsy, but can tell a man if there is cancer or not.

Men advised to have a biopsy should have at the next available time. Delaying the biospy can delay the diagnosis of cancer.

Preparation involved stopping blood thinning medication. On the day of the biopsy men will give themselves an enema prior to coming in for the biopsy. Men will also be given an antibiotic injection as well as taking an antibiotic prior to the biopsy to prevent infection

Men will be required to rest for a day or two after the biopsy. Most all men can then returns to normal activity following the procedure.